M Andreoni

Author PubWeight™ 56.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies. J Infect Dis 1996 2.34
2 Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 1999 2.10
3 Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst 1999 2.01
4 Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients. J Hepatol 2001 1.43
5 Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol 2005 1.42
6 Does HHV-8 have a protective role on the development of HIV encephalopathy? Italian HIV-Seroconversion Study. Neurology 1999 1.38
7 Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations. J Med Virol 2001 1.14
8 Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases. Scand J Infect Dis 1996 1.14
9 Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol 2001 1.10
10 Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity. Antiviral Res 1996 1.04
11 Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol 1999 1.04
12 A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. Eur J Epidemiol 2001 1.03
13 Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis 2000 1.02
14 A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone. Hepatology 2001 0.97
15 Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study. AIDS 2000 0.95
16 Correlates of Mycobacterium tuberculosis infection in a prison population. Eur Respir J 2005 0.95
17 HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. J Clin Microbiol 2011 0.94
18 Human herpesvirus-8 and other viral infections, Papua New Guinea. Emerg Infect Dis 2001 0.89
19 A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient. Int J Infect Dis 2009 0.88
20 Treatment of bone and soft tissue infections with teicoplanin. J Antimicrob Chemother 1990 0.88
21 HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity. AIDS 1997 0.86
22 Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS. AIDS 2001 0.85
23 Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. J Med Virol 2013 0.85
24 Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (Invirase) treatment. J Med Virol 1997 0.85
25 The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients. Clin Microbiol Infect 2012 0.84
26 Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea. Am J Trop Med Hyg 2005 0.84
27 Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection. Clin Microbiol Infect 2010 0.84
28 Population pharmacokinetics of rifabutin in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 1998 0.83
29 Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. J Med Virol 2004 0.81
30 Human herpes virus-8 infection among pregnant women and their children: results from the Sardinia-IDDM Study 2. Int J Cancer 2001 0.80
31 Protection from natural infection after live influenza virus immunization in an open population. J Hyg (Lond) 1979 0.80
32 A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin. Aliment Pharmacol Ther 2006 0.80
33 Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease. Ann Diagn Pathol 1999 0.80
34 Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials. Antiviral Res 1996 0.80
35 Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. Infection 2013 0.79
36 Prognostic factors of long-term CD4+count-guided interruption of antiretroviral treatment. J Med Virol 2009 0.79
37 Infection with human herpesvirus type 8 and kaposi's sarcoma in a central Italian area formerly endemic for malaria. Infection 2003 0.79
38 Neutralizing antibodies against autologous human immunodeficiency virus Type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment. Clin Diagn Lab Immunol 2001 0.78
39 Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre study. J Viral Hepat 2000 0.78
40 HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophages. Clin Exp Immunol 1998 0.78
41 Switching of inferred tropism caused by HIV during interruption of antiretroviral therapy. J Clin Microbiol 2010 0.78
42 Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapy. J Chemother 2011 0.78
43 A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection. Antivir Ther 1996 0.78
44 Absence of an effect of herpes simplex virus type 2 infection on HIV disease progression: data from a cohort of HIV-positive individuals with known date of seroconversion. AIDS 2001 0.77
45 Human herpesvirus 8 and human herpesvirus 2 infections in prison population. J Med Virol 2007 0.77
46 Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects. AIDS 1999 0.77
47 Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy. J Med Virol 2004 0.77
48 Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus. J Med Virol 2001 0.77
49 Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group. Eur J Gastroenterol Hepatol 2001 0.77
50 Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy. Clin Exp Immunol 2004 0.77
51 Distribution of the CCR5 delta32 allele in Italian HIV type 1-infected and normal individuals. AIDS Res Hum Retroviruses 2000 0.77
52 Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba. Br J Cancer 2002 0.77
53 Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections. Clin Infect Dis 1992 0.76
54 Predictability of sustained virological response to pegylated interferon alpha-2b Plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C virus infection. Curr HIV Res 2009 0.76
55 Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapy. Infection 2009 0.76
56 High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment. J Acquir Immune Defic Syndr 1994 0.75
57 Human immunodeficiency virus infection of human bone marrow stromal myoid cells. Scand J Infect Dis 1996 0.75
58 Human herpesvirus 8 in Brazilian Amerindians: does vertical transmission play a role? J Infect Dis 2000 0.75
59 Correlation between enzyme-linked immunosorbent assay and immunofluorescence assay with lytic antigens for detection of antibodies to human herpesvirus 8. Clin Diagn Lab Immunol 2001 0.75
60 Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. Diagn Microbiol Infect Dis 2001 0.75
61 Key questions in antiretroviral therapy: Italian Consensus Workshop (2005). J Antimicrob Chemother 2006 0.75
62 Discordant response to HAART: reduction of viremia and replicative capacity of HIV strains in patients after genotype guided change of therapy. New Microbiol 2004 0.75
63 Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients. J Chemother 2000 0.75
64 [Epidemiologic surveillance of influenza in Rome (1981-1982)]. Boll Ist Sieroter Milan 1984 0.75
65 Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient. Infection 2011 0.75
66 Five human immunodeficiency virus type 1 phenotypic variants with different MT-2 cell tropisms correlate with prognostic markers of disease. J Hum Virol 1999 0.75
67 [Clinico-epidemiologic study on 1258 cases of viral hepatitis admitted to Piedmont hospitals 1977-1979]. Minerva Med 1982 0.75
68 Serum IgG antibodies to human herpesvirus-6 (HHV-6) do not predict the progression of HIV disease to AIDS. Italian Seroconversion Study group. Eur J Epidemiol 1999 0.75
69 [Netilmicin and netilmicin-rifampicin combination in targeted treatment of staphylococcal infections]. Clin Ter 1986 0.75
70 Kaposi's sarcoma following malignant mesothelioma. Virchows Arch 1999 0.75
71 [Agarose selection of human lymphoid cells transformed in vitro by Epstein-Barr virus]. Ann Ist Super Sanita 1982 0.75
72 [Epidemiologic surveillance of influenza in Rome 1982-1984]. Quad Sclavo Diagn 1986 0.75
73 [Seroepidemiology of rubella in Rome (1972-1978)]. Boll Ist Sieroter Milan 1980 0.75
74 Rubella vaccination. Br Med J 1979 0.75
75 Ceftazidime in the therapy of pseudomonal meningitis. Chemioterapia 1985 0.75
76 [Antibody response to trivalent anti-influenza vaccination (inactivated virus) A/Texas/1/77 H3N2), A/URSS/90/77 (H1N1), B/Hong Kong/8/73]. Boll Ist Sieroter Milan 1982 0.75
77 [Influenza surveillance in Rome (1979-1980) (author's transl)]. Ann Sclavo 1982 0.75
78 In vitro activity of a new antibacterial drug, trospectomycin sulphate (U-63,366F), against Bacteroides strains isolated from the vagina. Chemotherapy 1993 0.75
79 [Pneumonia mortality in Italy over a 26-year period (1951-1976)]. Boll Ist Sieroter Milan 1982 0.75
80 [Epidemiological surveillance of influenza in rome in the 1978-1979 winter season]. Ann Sclavo 1982 0.75
81 Single radial haemolysis for rubella antibody screening. Boll Ist Sieroter Milan 1980 0.75
82 Clearance of human herpesvirus 8 from blood and regression of leukopenia-associated aggressive classic Kaposi's sarcoma during interferon-alpha therapy: a case report. Clin Infect Dis 2001 0.75
83 [Circulation of three types of influenza A virus in the Roman population during the winter of 1977-78]. Nuovi Ann Ig Microbiol 1981 0.75
84 [Statistical comparison of the bacteriostatic and bactericidal activity of beta-lactams and aminoglycosides on hospital bacteria strains (Pavia-Novara)]. G Ital Chemioter 1986 0.75
85 Antiviral potency of HAART regimens and clinical success are not strictly coupled in real life conditions: evidence from the MASTER-1 study. HIV Clin Trials 2001 0.75
86 [Clinical picture of Reye's syndrome in an adult]. Minerva Med 1980 0.75
87 [Study of bronchoalveolar lavage in febrile patients with AIDS or AIDS-related syndrome]. Recenti Prog Med 1987 0.75
88 [A survey on dental offices: risk assessment and practicable preventive and protective measures]. G Ital Med Lav Ergon 2013 0.75
89 [Rubella immunity among unvaccinated young women (author's transl)]. Ann Sclavo 1982 0.75
90 Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. Infection 2011 0.75
91 [Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon]. Recenti Prog Med 2001 0.75
92 Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT). Infection 2014 0.75
93 [Epidemiological surveillance of influenza in Rome (1980-1981)]. Ann Sclavo 1983 0.75
94 Comparison of complement fixation, immunofluorescence and immunoenzymatic tests for routine detection of cytomegalovirus IgG antibodies. Boll Ist Sieroter Milan 1984 0.75
95 [Antibody response to an anti-influenza vaccine of inactivated whole virus, titrated in micrograms, used in the 1980/81 season]. Boll Ist Sieroter Milan 1982 0.75